Literature DB >> 30215111

Current concepts and challenges in the radiologic assessment of brain tumors in children: part 2.

Benita Tamrazi1, Kshitij Mankad2, Marvin Nelson3, Felice D'Arco2.   

Abstract

Assessing tumor response is a large part of everyday clinical work in neuroradiology. However in the setting of tumor treatment, distinguishing tumor progression from treatment-related changes is difficult on conventional MRI sequences. This is made even more challenging in children where mainstay advanced imaging techniques that are often used to decipher progression versus treatment-related changes have technical limitations. In this review, we highlight the challenges in pediatric neuro-oncologic tumor assessment with discussion of pseudophenomenon including pseudoresponse and pseudoprogression. Additionally, we discuss the advanced imaging techniques often employed in neuroradiology to distinguish between pseudophenomenon and true progressive disease.

Entities:  

Keywords:  Children; Immunotherapy; Magnetic resonance diffusion; Magnetic resonance perfusion; Magnetic resonance spectroscopy; Pediatric neuro-oncology; Pseudoprogression; Pseudoresponse

Mesh:

Substances:

Year:  2018        PMID: 30215111     DOI: 10.1007/s00247-018-4232-7

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  61 in total

1.  Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study.

Authors:  Sridharan Gururangan; Susan N Chi; Tina Young Poussaint; Arzu Onar-Thomas; Richard J Gilbertson; Sridhar Vajapeyam; Henry S Friedman; Roger J Packer; Brian N Rood; James M Boyett; Larry E Kun
Journal:  J Clin Oncol       Date:  2010-05-17       Impact factor: 44.544

2.  Differentiation of tumor progression from pseudoprogression in patients with posttreatment glioblastoma using multiparametric histogram analysis.

Authors:  J Cha; S T Kim; H-J Kim; B-J Kim; Y K Kim; J Y Lee; P Jeon; K H Kim; D-S Kong; D-H Nam
Journal:  AJNR Am J Neuroradiol       Date:  2014-03-27       Impact factor: 3.825

Review 3.  Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas.

Authors:  Frederic G Dhermain; Peter Hau; Heinrich Lanfermann; Andreas H Jacobs; Martin J van den Bent
Journal:  Lancet Neurol       Date:  2010-08-10       Impact factor: 44.182

4.  Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors.

Authors:  Eric M Thompson; Daniel J Guillaume; Edit Dósa; Xin Li; Kellie J Nazemi; Seymur Gahramanov; Bronwyn E Hamilton; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2012-04-19       Impact factor: 4.130

5.  Apparent diffusion coefficient: a quantitative parameter for in vivo tumor characterization.

Authors:  Andreas M Herneth; Samira Guccione; Mark Bednarski
Journal:  Eur J Radiol       Date:  2003-03       Impact factor: 3.528

6.  Pseudoprogression in Patients with Glioblastoma: Assessment by Using Volume-weighted Voxel-based Multiparametric Clustering of MR Imaging Data in an Independent Test Set.

Authors:  Ji Eun Park; Ho Sung Kim; Myeong Ju Goh; Sang Joon Kim; Jeong Hoon Kim
Journal:  Radiology       Date:  2015-01-21       Impact factor: 11.105

7.  Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients.

Authors:  Vaios Hatzoglou; Gary A Ulaner; Zhigang Zhang; Kathryn Beal; Andrei I Holodny; Robert J Young
Journal:  Clin Imaging       Date:  2012-10-12       Impact factor: 1.605

8.  Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.

Authors:  Teri N Kreisl; Lyndon Kim; Kraig Moore; Paul Duic; Cheryl Royce; Irene Stroud; Nancy Garren; Megan Mackey; John A Butman; Kevin Camphausen; John Park; Paul S Albert; Howard A Fine
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

9.  Discrepant MR and [(18)F]Fluoroethyl-L-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure.

Authors:  Norbert Galldiks; Christian P Filss; Roland Goldbrunner; Karl-Josef Langen
Journal:  Case Rep Oncol       Date:  2012-09-08

Review 10.  The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.

Authors:  Norbert Galldiks; Ian Law; Whitney B Pope; Javier Arbizu; Karl-Josef Langen
Journal:  Neuroimage Clin       Date:  2016-12-18       Impact factor: 4.881

View more
  3 in total

1.  A Diagnostic Algorithm for Posterior Fossa Tumors in Children: A Validation Study.

Authors:  C A P F Alves; U Löbel; J S Martin-Saavedra; S Toescu; M H Tsunemi; S R Teixeira; K Mankad; D Hargrave; T S Jacques; C da Costa Leite; F G Gonçalves; A Vossough; F D'Arco
Journal:  AJNR Am J Neuroradiol       Date:  2021-03-04       Impact factor: 3.825

2.  The impact of magnetic resonance imaging spectroscopy parameters on differentiating between paediatric medulloblastoma and ependymoma.

Authors:  Nguyen Minh Duc
Journal:  Contemp Oncol (Pozn)       Date:  2021-05-06

Review 3.  Glioma surveillance imaging: current strategies, shortcomings, challenges and outlook.

Authors:  Gehad Abdalla; Ahmed Hammam; Mustafa Anjari; Dr Felice D'Arco; Dr Sotirios Bisdas
Journal:  BJR Open       Date:  2020-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.